Literature DB >> 25351619

Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases.

Belal Chaudhary1, Eyad Elkord.   

Abstract

OBJECTIVES: Neuropilin 1 (NRP1) is a transmembrane protein with diverse roles in physiological and pathological settings. NRP1 expression has been reported on T cells in inflammatory microenvironments and in secondary lymphoid tissue. Tumor-infiltrating lymphocytes (TILs) play an important role in cancer prognosis. In this study, we investigated NRP1 expression on TILs and peripheral blood mononuclear cells (PBMCs) from colorectal cancer liver metastases (LI/CRC).
METHODS: TILs from LI/CRC and PBMCs from healthy donors and patients were analyzed for expression of NRP1, in addition to other Treg-related markers. PBMCs were co-cultured in vitro with tumor tissue and analyzed for NRP1 expression.
RESULTS: We report for the first time that NRP1 is highly expressed on CD3(+)CD4(+) TILs compared to PBMCs. NRP1 expression correlated closely with CD25 expression in TILs. NRP1 was expressed on both Helios(+) and Helios(-) FoxP3-expressing Tregs and on a FoxP3(-)Helios(-) T cell subset. It was also induced on PBMCs following in vitro co-culture with tumor tissue.
CONCLUSIONS: NRP1 is upregulated on TILs and can be induced on PBMCs by tumor tissue. Further studies are warranted to define the function of NRP1 on human TILs. As a therapeutic target, NRP1 may allow selective targeting of TIL subsets including suppressive Tregs.

Entities:  

Keywords:  Neuropilin 1; colorectal cancer liver metastases; expression; regulatory T cells; tumor-infiltrating lymphocytes

Mesh:

Substances:

Year:  2014        PMID: 25351619     DOI: 10.1517/14728222.2014.977784

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  13 in total

Review 1.  Modulation of regulatory T cell function and stability by co-inhibitory receptors.

Authors:  Liliana E Lucca; Margarita Dominguez-Villar
Journal:  Nat Rev Immunol       Date:  2020-04-08       Impact factor: 53.106

2.  Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity.

Authors:  Abigail E Overacre-Delgoffe; Maria Chikina; Rebekah E Dadey; Hiroshi Yano; Erin A Brunazzi; Gulidanna Shayan; William Horne; Jessica M Moskovitz; Jay K Kolls; Cindy Sander; Yongli Shuai; Daniel P Normolle; John M Kirkwood; Robert L Ferris; Greg M Delgoffe; Tullia C Bruno; Creg J Workman; Dario A A Vignali
Journal:  Cell       Date:  2017-05-25       Impact factor: 41.582

3.  Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients.

Authors:  Alhasan Alsalman; Mohammad A Al-Mterin; Khaled Murshed; Ferial Alloush; Samia T Al-Shouli; Salman M Toor; Eyad Elkord
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

Review 4.  Semaphorin 3A in the Immune System: Twenty Years of Study.

Authors:  Ekaterina P Kiseleva; Kristina V Rutto
Journal:  Biochemistry (Mosc)       Date:  2022-07       Impact factor: 2.824

5.  Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.

Authors:  Shouhua Yang; Henghui Cheng; Zaiju Huang; Xiaoling Wang; Yinglu Wan; Jing Cai; Zehua Wang
Journal:  Dis Markers       Date:  2015-03-19       Impact factor: 3.434

Review 6.  Neuropilin-1 as Therapeutic Target for Malignant Melanoma.

Authors:  Grazia Graziani; Pedro M Lacal
Journal:  Front Oncol       Date:  2015-06-03       Impact factor: 6.244

Review 7.  Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy.

Authors:  Sohini Roy; Arup K Bag; Rakesh K Singh; James E Talmadge; Surinder K Batra; Kaustubh Datta
Journal:  Front Immunol       Date:  2017-10-10       Impact factor: 7.561

8.  Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.

Authors:  Ya Guo; Zhong Wei Wang; Wang Hui Su; Jing Chen; Ya Li Wang
Journal:  Biomed Res Int       Date:  2020-06-27       Impact factor: 3.411

9.  Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1.

Authors:  Marine Leclerc; Elodie Voilin; Gwendoline Gros; Stéphanie Corgnac; Vincent de Montpréville; Pierre Validire; Georges Bismuth; Fathia Mami-Chouaib
Journal:  Nat Commun       Date:  2019-07-26       Impact factor: 14.919

Review 10.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.